Geron Corp. (GERN)
1.88
-0.04
(-2.08%)
USD |
NASDAQ |
Feb 20, 16:00
1.85
-0.03
(-1.60%)
After-Hours: 20:00
Geron SG&A Expense (Quarterly) : 39.00M for Sept. 30, 2025
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Plus Therapeutics, Inc. | 3.443M |
| Insmed, Inc. | 212.48M |
| SELLAS Life Sciences Group, Inc. | 2.867M |
| Rezolute, Inc. | 9.873M |
| GT Biopharma, Inc. | 2.748M |